GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up ...
FTSE 100 Live 10 October: Index higher, GSK shares rise on $2.2bn Zantac settlement
US economic optimism last night helped the S&P 500 index to set its 44th record high this year, having improved by another ...
GSK shares jump after settlement of 80,000 Zantac lawsuits in U.S
The agreement, announced on Wednesday, was far lower than some analyst estimates, including JP Morgan's projection of $3.5 ...
pharmaphorum31m
Ex-Pfizer leaders side with firm against activist investor
Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...
London South East35m
LONDON BRIEFING: Tritax EuroBox backs Brookfield bid in blow for Segro
GSK agreed to pay up to USD2.2 billion to settle the vast majority of cases linked to its heartburn medicine Zantac. In a statement on Wednesday, the London-based pharmaceuticals firm said that it had ...
Tritax bid battle takes fresh twist with new £1.1 bn cash offer from Brookfield
Toronto headquartered Brookfield, which is 50% owner of Canary Wharf alongside the Qatari Investment Authority and has around ...
AlKhaleej Today44m
UK firm GSK to pay $2.2bn over Zantac cancer claims
LONDON — UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts ...